Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan-Reference-Cited by-同舟云学术

Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan

Published:2022-05-28 Issue:8 Volume:57 Page:1304-1312
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Guijarro Francesca^ORCID,Bataller Alex^ORCID,Diaz-Beyá Marina,Garrido Ana,Coll-Ferrà Christelle^ORCID,Vives Susana,Salamero Olga^ORCID,Valcárcel David,Tormo Mar^ORCID,Arnan Montserrat,Sampol Antònia^ORCID,Castaño-Díez Sandra,Martínez Carmen^ORCID,Suárez-Lledó María,Fernández-Avilés Francesc,Hernández-Boluda Juan Carlos^ORCID,Ribera Josep Maria,Rovira Montserrat,Brunet Salut,Sierra Jorge^ORCID,Esteve Jordi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-022-01703-9.pdf

Reference37 articles.

1. Heuser M, Ofran Y, Boissel N, Brunet Mauri S, Craddock C, Janssen J, et al. Acute myeloid leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2020;31:697–712.

2. Bergua JM, Montesinos P, Martinez-Cuadrón D, Fernández-Abellán P, Serrano J, Sayas MJ, et al. A prognostic model for survival after salvage treatment with FLAG-Ida +/− gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia. Br J Haematol. 2016;174:700–10.

3. Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Ebert BL, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–48.

4. Montesinos P, Bergua J, Infante J, Esteve J, Guimaraes JE, Sierra J, et al. Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus. Ann Hematol. 2020;99:675.

5. Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120:2454–65.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the role of long non-coding RNAs in therapeutic resistance in acute myeloid leukemia: New prospects & challenges;Non-coding RNA Research;2024-12

2. Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia;Cells;2024-04-26

3. Antineoplastics;Reactions Weekly;2022-09-10